News Mylan recalls pricey US EpiPens, but cheaper version unaffec... More trouble for embattled Mylan.
News As market declines, Purdue hopes to kick opiate habit Amid opiate crisis, Purdue looks for abuse-deterrent alternatives.
News Mylan recalls 81,000 EpiPens after reports of failures Recall follows two reports that allergy injection device failed.
News Risks of Endo painkiller outweigh benefits, say FDA advisers The US regulator must make a decision on Endo Pharmaceuticals’ opioid painkiller, after its independent advisers said that the risks of abuse now outweigh its benefits.
News Another NHS hospital safety lapse 'inevitable' warns Francis Care standards could be compromised in underfunded NHS, warns QC.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
